News

Revolutionizing Clinical Care: Upgrades in ClinicalKey AI

Revolutionizing Clinical Care: Upgrades in ClinicalKey AI

Enhancements in ClinicalKey AI for Better Patient Outcomes

Elsevier, a pioneering force in health information and analytics, has initiated significant upgrades to its flagship clinical decision support tool, ClinicalKey AI. This advanced generative AI platform is designed to facilitate healthcare providers in accessing critical, evidence-based insights right when they need them—enhancing both patient care and clinical efficiency.

New Functionalities Streamline Clinician Workflows

For medical professionals, time is of the essence. That’s why these latest enhancements aim at creating seamless workflows. With the new capabilities, clinicians can now integrate ClinicalKey AI directly with electronic health records (EHR), particularly through partnerships with Epic and the health information technology platform iPrescribe by DrFirst. Additionally, a newly launched mobile app caters to busy healthcare providers, granting them easy access while on the move.

Intuitive EHR Integration Enhancing Access

The integration of ClinicalKey AI with Epic's EHR allows clinicians to transition easily between the patient's electronic record and the clinical information they need, without the hassle of switching contexts. This functionality signifies a groundbreaking effort in providing a smoother continuum of care where clinicians can focus more on their patients and less on administrative hurdles.

Mobile Accessibility for On-the-Go Healthcare

The emergence of a mobile app marks a significant shift in how healthcare professionals can access vital medical information. This app empowers clinicians to engage with evidence-based content directly from their smartphones, fostering informed decision-making in real-time, irrespective of their physical location.

Further Enhancements to Support Continuing Education

Not only does ClinicalKey AI revolutionize access to invaluable information, but it also fosters ongoing education for healthcare professionals by facilitating the earning of Continuing Medical Education (CME) and Maintenance of Certification (MOC) credits. Clinicians can now effortlessly log these credits through everyday interactions with clinical queries, further incorporating learning in their daily practices.

Auto-Submission of MOC Credits

This platform sets a precedent as it offers the unique capability of auto-submitting MOC credits to American Boards across various specialties including internal medicine, pediatrics, and more. This feature illustrates ClinicalKey AI's commitment to supporting clinical professionals in their ongoing development amidst a demanding environment.

A Voice from Leadership on Impacting Clinical Decisions

Omry Bigger, President of Clinical Solutions, remarked on the importance of these changes: "Clinicians today face relentless pressures while providing care. ClinicalKey AI is centered on easing these challenges with advanced, intuitive technology that combines efficient access to research and education in one place." This perspective aligns with the broader vision of redefining healthcare accessibility and knowledge.

Global Availability and Comprehensive Resources

ClinicalKey AI now reaches over 50 countries, bringing with it a curated trove of information aimed at answering the pressing questions healthcare workers have at the point of care. The platform boasts a mix of materials from notable Elsevier titles such as The Lancet and Goldman-Cecil, along with other trusted evidence-based resources.

Looking Ahead: Further Collaborations and Innovations

Elsevier's commitment to healthcare innovation continues with partnerships designed to enhance clinical practice. Recent collaborations, including one with the American College of Cardiology, have broadened the scope of accessible clinical practice guidelines. Such initiatives reflect Elsevier’s overarching goal of ensuring healthcare professionals are equipped with the best tools and insights to deliver optimal patient care.

About Elsevier

As a world leader in scientific information and analytics, Elsevier has dedicated over 140 years to transforming the landscape of health and research. Its insights facilitate evidence-based decision-making across various sectors, including healthcare, research, and education. With a global team of 9,500, including a significant number of technologists, Elsevier remains at the forefront of fostering healthcare innovations that improve patient outcomes.

About iPrescribe by DrFirst

DrFirst’s iPrescribe solution is trusted nationwide for e-prescribing, offering healthcare providers a reliable tool to facilitate compliant prescriptions across diverse healthcare environments. It serves as an essential resource, ensuring that safety and efficiency come first when it comes to medication management.

Frequently Asked Questions

What is ClinicalKey AI?

ClinicalKey AI is a generative AI-powered clinical decision support tool by Elsevier designed to enhance workflows and access to evidence-based insights for clinicians.

How does ClinicalKey AI integrate with electronic health records?

The tool integrates seamlessly with platforms like Epic to provide real-time access to clinical information without disrupting patient care.

What new features are included in the ClinicalKey AI upgrade?

The latest features include EHR integrations, a mobile app, and capabilities for earning CME and MOC credits within the platform.

Who can benefit from ClinicalKey AI?

Healthcare providers across various practices and specialties can leverage ClinicalKey AI for superior access to clinical information and ongoing education.

Is ClinicalKey AI available globally?

Yes, ClinicalKey AI is now available in over 50 countries, reflecting its global reach and commitment to supporting clinicians worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 392

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 169

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 406

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 257

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 390

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 265

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 398

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Mycoplasma Testing: Future Growth and Trends

Updated Category News Views 102

Insights into the Growth of the Mycoplasma Testing Market The mycoplasma testing market is expected to balloon to USD 2.49 billion in the next few years. This impressive growth stems largely from the increasing use of cell culture techniques within biopharmaceutical research and development. As researchers and companies adopt these advanced methods, the demand for...

Continue Reading
Investors Urged to Examine Claims Against Toronto-Dominion Bank

Updated Category News Views 65

Faruqi & Faruqi Investigates Toronto-Dominion Bank Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors who have suffered significant financial losses from their investments in The Toronto-Dominion Bank (NYSE: TD). The firm is reaching out to investors who experienced losses exceeding $100,000,...

Continue Reading
Heifer International Advocates for Farmer Support Amidst Crisis

Updated Category News Views 403

Heifer International Advocates for Farmer Support Amid Climate Crisis Heifer International is calling for urgent action to assist smallholder farmers affected by the extreme weather patterns brought on by climate change. The recent impact of Tropical Depression Sara highlights the vulnerability of agricultural communities across Central America, prompting the organization...

Continue Reading
Mitsubishi Tanabe Pharma Unveils RADICAVA ORS Insights at NASP

Updated Category News Views 135

Mitsubishi Tanabe Pharma America Unveils Data on RADICAVA ORS Mitsubishi Tanabe Pharma America, Inc. (MTPA) is thrilled to share vital information regarding their innovative product, RADICAVA ORS (edaravone), at an upcoming event designed for specialized pharmacy professionals. This presentation aims at enhancing the understanding of it’s application in managing...

Continue Reading
Warren Buffett's Coca-Cola Dividend Strategy: A Love Affair

Updated Category News Views 593

Warren Buffett's Love for Coca-Cola Warren Buffett, a legendary investor, is set to receive a staggering $776 million in dividends from Coca-Cola. This immense wealth from his investment in Coca-Cola illustrates the power of dividends in wealth accumulation. Buffett's investment journey with Coca-Cola has not only been fruitful financially but has also created a personal...

Continue Reading